Logo do repositório
 
Publicação

Influenza vaccination in older adults and patients with chronic disorders

dc.contributor.authorFroes, F.
dc.contributor.authorTimóteo, A.
dc.contributor.authorAlmeida, B.
dc.contributor.authorRaposo, J. F.
dc.contributor.authorOliveira, J.
dc.contributor.authorCarrageta, M.
dc.contributor.authorDuque, S.
dc.contributor.authorMorais, A.
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.pblElsevier Espana S.L.U
dc.date.accessioned2024-01-24T16:58:23Z
dc.date.available2024-01-24T16:58:23Z
dc.date.issued2024-09
dc.descriptionFunding Information: The Infectious Disease Society of America recommends annual IIV immunization for immunocompromised individuals older than 6 months. 119 This group of patients includes people with HIV infection with solid organ or hematological malignancies and people on long-term immunosuppressive therapy. The recommendation is supported by the CDC, the American Society of Blood and Marrow Transplantation, and the European Group for Blood and Marrow Transplantation, although the recommended windows for vaccination differ. While the US guidelines support lifelong immunization, 121 European guidelines encourage tailoring decisions to individual patients. 120 Patients who are highly unlikely to respond, such as those receiving intensive induction or consolidation chemotherapy for acute leukemia or those who have recently received anti-B-cell antibodies are the only patients who should not be administered IIVs. 119 Publisher Copyright: © 2023 Sociedade Portuguesa de Pneumologia
dc.description.abstractInfluenza affects millions of people worldwide each year and can lead to severe complications, hospitalizations, and even death, especially among vulnerable populations such as older adults and those with chronic medical conditions. Annual vaccination is considered the most effective measure for preventing influenza and its complications. Despite the widespread availability of influenza vaccines, however, vaccination coverage rates remain suboptimal in several countries. Based on the latest scientific evidence and expert opinions on influenza vaccination in older people and patients with chronic disease, the Portuguese Society of Pulmonology (SPP), the Portuguese Society of Diabetology (SPD), the Portuguese Society of Cardiology (SPC), the Portuguese Society of Geriatrics and Gerontology (SPGG), the Study Group of Geriatrics of the Portuguese Society of Internal Medicine (NEGERMI-SPMI), and the Portuguese Society of Infectious Diseases and Clinical Microbiology (SPDIMC) discussed best practices for promoting vaccination uptake and coverage and drew up several recommendations to mitigate the impact of influenza. These recommendations focus on the efficacy and safety of available vaccines; the impact of influenza vaccination on older adults; patients with chronic medical conditions, namely cardiac and respiratory conditions, diabetes, and immunosuppressive diseases; and health care professionals, optimal vaccination timing, and strategies to increase vaccination uptake and coverage. The resulting position paper highlights the critical role that vaccinations play in promoting public health, raising awareness, and encouraging more people to get vaccinated.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent526540
dc.identifier.doi10.1016/j.pulmoe.2023.11.003
dc.identifier.issn2531-0429
dc.identifier.otherPURE: 81482489
dc.identifier.otherPURE UUID: 96867499-6286-433d-99ef-98afeefd3fa9
dc.identifier.otherScopus: 85180593969
dc.identifier.otherPubMed: 38129238
dc.identifier.otherWOS: 001440959000001
dc.identifier.urihttp://hdl.handle.net/10362/162703
dc.identifier.urlhttps://www.scopus.com/pages/publications/85180593969
dc.language.isoeng
dc.peerreviewedyes
dc.subjectChronic conditions
dc.subjectFlu
dc.subjectInfluenza
dc.subjectOlder people
dc.subjectRecommendations
dc.subjectVaccination
dc.subjectPulmonary and Respiratory Medicine
dc.subjectSDG 3 - Good Health and Well-being
dc.titleInfluenza vaccination in older adults and patients with chronic disordersen
dc.title.subtitleA position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Diabetology, the Portuguese Society of Cardiology, the Portuguese Society of Geriatrics and Gerontology, the Study Group of Geriatrics of the Portuguese Society of Internal Medicine, and the Portuguese Society of Infectious Diseases and Clinical Microbiologyen
dc.typejournal article
degois.publication.firstPage422
degois.publication.issue5
degois.publication.lastPage436
degois.publication.titlePulmonology
degois.publication.volume30
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
1-s2.0-S2531043723002015-main.pdf
Tamanho:
514.2 KB
Formato:
Adobe Portable Document Format